2026-04-13T04:16:29Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1800872026-02-26T01:34:07Zcom_2072_1057col_2072_478798col_2072_478916col_2072_478917col_2072_478929

00925njm 22002777a 4500 dc Frias Gomez, Jon author Tovar, Eva author Vidal, August author Murgui, Lluis author Ibáñez, Raquel author Peremiquel Trillas, Paula author Paytubi Casabona, Sònia author Baixeras, Nuria author Zanca, Alba author Ponce i Sebastià, Jordi author Pineda, Marta author Brunet, Joan author Sanjosé Llongueras, Silvia de author Bosch, F. Xavier author Matias-Guiu, Xavier, 1958- author Alemany, Laia author Costas, Laura author Screenwide Team author 2021-09-17T08:40:37Z 2021-09-17T08:40:37Z 2021-09-04 2021-09-16T07:57:52Z Introduction: Cervical cytology is a well-stablished cervical cancer screening method. However, due to the anatomical continuity of the genital tract, it can also detect signs of endometrial disease. Our aim was to estimate the sensitivity of cervical cytology in endometrial cancer detection and prognosis in a large population over a 30-year period in a large academic tertiary hospital in Spain. Methodology: We performed a search for women diagnosed with endometrial cancer from 1990 to 2020, who were surgically treated and had a previous cervical cytology result. Information Technologies Department databases from Bellvitge University Hospital and the Screenwide case-control study's database were used. Cervical cytology results were classified as abnormal when squamous lesions, glandular atypia or malignant cells were identified. Results: Overall, we evaluated 371 women with endometrial cancer and a documented cervical cytology performed within 3 years previous to surgical treatment. Overall, the sensitivity of cervical cytology for endometrial cancer detection was 25.6%. Several clinico-pathological characteristics, such as non-endometrioid histology and a higher stage, were correlated with higher sensitivity. Càncer d'endometri Citodiagnòstic Endometrial cancer Cytodiagnosis Sensitivity of cervical cytology in endometrial cancer detection in a tertiary hospital in Spain